2018-12-05

PRESS RELEASE: Comments on WHO’s Critical Reviews of CBD and Extracts and Tinctures of cannabis, and EIHA recommendations to WHO on low-THC preparations from industrial hemp

On July 23, 2018, WHO published outcomes of 40th meeting of Expert Committee on Drug Dependence (ECDD) with its final recommendations on Cannabidiol. On November 12, 2018, a 41st session of ECDD convened again at WHO headquarters in Geneva to discuss Critical reviews on Cannabis and resin, Extracts and tinctures of cannabis, Delta9-THC and isomers of THC. As EIHA was allowed to submit a written statement to WHO experts for the third time in 18 months, EIHA aligned again with FAAAT and ICCI experts to have its formal say.

PDF-download here: 18-12-05 PR WHO CBD